Tumor-inhibiting properties of the neutral P-O-ethyl ester of adenosine 3':5'-monophosphate in correlation with its crystal and molecular structure.
- 1 April 1975
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 72 (4) , 1335-1339
- https://doi.org/10.1073/pnas.72.4.1335
Abstract
The P-O-ethyl ester of cAMP has been synthesized, its inhibition of solid and ascites tumors studied, and its pattern of urinary excretion followed. Et-cAMP is more effective than cAMP against solid sarcoma 180 in mice and against Ehrlich ascites carcinoma cells in tissue culture. The urinary excretion pattern of injected E-t-cAMP suggests that about two-thirds of the injected dose (13 mumol per animal) is retained in the rat rather than being promptly excreted. Liver slice studies of the effect on glycogenolysis suggest that the Et-cAMP is converted to cAMP intracellularly. The compound crystallizes in space group P21 with one molecule per asymmetric unit. The base ring has the anti conformation. The ethyl group is endo to the base ring and is axial in the flattened chair-conformer six-membered ring formed by the 3'-5' O-P-O cyclization. In most other respects the structure of the compound is closely similar to the known structures of other cyclic nucleotides.Keywords
This publication has 21 references indexed in Scilit:
- Phosphate basicity and nucleophilicity loss upon constraint: The role of the alkoxy oxygensBioinorganic Chemistry, 1974
- Studies on neutral esters of cyclic AMPBiochemical and Biophysical Research Communications, 1973
- Possibilities for drug development based on the cyclic AMP systemLife Sciences, 1973
- Conformational analysis of the sugar ring in nucleosides and nucleotides. New description using the concept of pseudorotationJournal of the American Chemical Society, 1972
- Nucleic acids and constituents. XXVII. Crystal structure of 5'-methylene adenosine 3',5'-cyclic monophosphonate monohydrate, biologically active analog of the secondary hormonal messenger cyclic adenosine 3',5'-monophosphate. Conformational rigidity furanose ring in cyclic nucleotidesJournal of the American Chemical Society, 1972
- Stereochemistry of nucleic acids and their constituents. XII. Crystal and molecular structure of .alpha.-D-2'-amino-2'-deoxyadenosine monohydrateJournal of the American Chemical Society, 1970
- Mutagenicity of Trimethylphosphate in MiceScience, 1970
- The crystal and molecular structure of the triethylammonium salt of cyclic uridine-3',5'-phosphateActa Crystallographica Section B: Structural Science, Crystal Engineering and Materials, 1969
- Short-term toxicity studies of rats fed triethyl phosphate in the dietToxicology and Applied Pharmacology, 1968
- Derivatives of cyclic 3′,5′-adenosine monophosphateBiochimica et Biophysica Acta, 1962